On July 15, 2020 IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQB: IGXT) (the "Company" or "IntelGenx") reported , that the Company’s Board of Directors approved an amendment to the Amended 2016 Stock Option Plan (the "Plan") to increase the number of shares available for issuances under the Plan by 1,678,218 from 9,347,747 to 11,025,965, or 10% of the Company’s currently issued and outstanding shares (Press release, IntelGenx, JUL 15, 2020, View Source [SID1234561877]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Furthermore, the Board approved an amendment to the provision concerning the automatic extension of the expiry time of stock options during blackout periods as per the TSX-V Exchange Policy. The Board resolved to remove the condition that the automatic extension during blackout periods needs to be reflected in individual stock option agreements.

The amendments are subject to TSX-Venture Exchange acceptance.

The Second Amended 2016 Stock Option Plan will be available on EDGAR and SEDAR.